Official press releases or policy announcements from Wall Street banks

Report Reveals 27% Rise in Adderall Prescriptions as Young Wall Street Bankers Use Stimulants for 22-Hour Work Days

Dec 16, 2024, 10:50 AM

A recent report highlights the increasing use of ADHD medications, particularly Adderall and Vyvanse, among young bankers on Wall Street. Interviews with over 50 current and former investment bankers reveal that many view these stimulants as essential tools to manage the long hours and intense pressure of their jobs. The report indicates that the use of these drugs is openly discussed in workplaces, with some bankers reportedly taking ever-increasing doses to cope with demanding 100-hour work weeks. A doctor who prescribes ADHD medications noted that many patients consider stimulants akin to multivitamins or dietary supplements. Data from Truveta shows a 27% rise in first-time Adderall prescriptions, underscoring the growing reliance on these substances in the finance sector. The findings raise concerns about a potential drug problem in the industry, as some bankers reportedly resort to snorting crushed Adderall to endure grueling workdays that can stretch up to 22 hours.